Search research articles
Contact Us
Filters
Showing results (521-530 of 538) with videos related to
Page
of 54
Sort By:
Cancer Cell
|
February 23, 2010
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
Patrick S Ward, Jay Patel, David R Wise, et al.
Journal - Association of Official Analytical Chemists
|
November 1, 1981
Citrus artifact interference in aflatoxin M1 determination in milk
R L Price, K V Jorgensen, M Billotte, et al.
JAMA Oncology
|
November 17, 2022
Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial
Timothy A Yap, Aditya Bardia, Michael Dvorkin, et al.
European Radiology
|
January 6, 2026
Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results
Sungmin Woo, Angela Tong, Anton S Becker, et al.
The Prostate
|
March 29, 2023
Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile
Victor R Adorno Febles, Yuan Hao, Aarif Ahsan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
June 11, 2025
Outpatient or Inpatient Setting for Cervical Ripening Before Induction of Labour: An Individual Participant Data Meta-Analysis
Malitha Patabendige, Fei Chan, Michelle R Wise, et al.
Prostate Cancer and Prostatic Diseases
|
September 22, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients
Neal D Shore, Christopher M Pieczonka, Sean Heron, et al.
JNCI Cancer Spectrum
|
June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
Neil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.
The Journal of Urology
|
August 9, 2024
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer
Neal Shore, Christopher Pieczonka, Sean Heron, et al.
JCO Precision Oncology
|
March 7, 2024
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing
Stacy Loeb, Scott W Keith, Heather H Cheng, et al.
Page
of 54
Search research articles
Search
Showing results (521-530 of 538) with videos related to
Sort By:
Page
of 54
Cancer Cell
|
February 23, 2010
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
Patrick S Ward, Jay Patel, David R Wise, et al.
Journal - Association of Official Analytical Chemists
|
November 1, 1981
Citrus artifact interference in aflatoxin M1 determination in milk
R L Price, K V Jorgensen, M Billotte, et al.
JAMA Oncology
|
November 17, 2022
Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial
Timothy A Yap, Aditya Bardia, Michael Dvorkin, et al.
European Radiology
|
January 6, 2026
Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results
Sungmin Woo, Angela Tong, Anton S Becker, et al.
The Prostate
|
March 29, 2023
Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile
Victor R Adorno Febles, Yuan Hao, Aarif Ahsan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
June 11, 2025
Outpatient or Inpatient Setting for Cervical Ripening Before Induction of Labour: An Individual Participant Data Meta-Analysis
Malitha Patabendige, Fei Chan, Michelle R Wise, et al.
Prostate Cancer and Prostatic Diseases
|
September 22, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients
Neal D Shore, Christopher M Pieczonka, Sean Heron, et al.
JNCI Cancer Spectrum
|
June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
Neil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.
The Journal of Urology
|
August 9, 2024
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer
Neal Shore, Christopher Pieczonka, Sean Heron, et al.
JCO Precision Oncology
|
March 7, 2024
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing
Stacy Loeb, Scott W Keith, Heather H Cheng, et al.
Page
of 54